Lutetium-177 Octreotate Therapy: Your Questions Answered
What Is Lutetium-177 Octreotate Therapy? One of the therapies used to treat neuroendocrine tumours is Lutetium-177 Octreotate Therapy. It is a targeted radioligand therapy that specially targets tumours that express somatostatin receptors (i.e. neuroendocrine tumours). Its method of action consists of using peptide molecules such as artificial octreotate – transport – linked to a carrier […]